Viewing Study NCT02634294

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:31 AM
Ignite Modification Date: 2026-07-03 @ 9:11 AM
Study NCT ID: NCT02634294
Status: COMPLETED
Last Update Posted: 2023-03-16
First Post: 2015-12-05
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Peg Interferon α-2b for Relapsed Hematological Malignancies After Allo-HSCT
Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hematological Neoplasms View
None Recurrence View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Hematological Neoplasms View
None recurrence View
None Hematopoietic Stem Cell Transplantation View
None peginterferon alfa-2b View
None Graft vs Host Disease View